Cabot Corporation's (CBT) shares have increased 16.1% in the past three months compared with the industry and the S&P 500's growth of 5% and 4.8%, respectively. Image Source: Zacks Investment Research Let's look at the factors driving the stock's price appreciation. What's Driving Cabot Stock? Cabot's Performance Chemicals division experienced strong growth in the fiscal third quarter, with sales rising 8.1% year over year to $332 million. The segment's EBIT saw an impressive 72% jump to $55 million, fueled ...

The Fed kicked off the new rate cycle era by initiating a 50 basis points cut in interest rates after holding it at a 23-year high for 14 consecutive months since July 2023. This marked the first rate cut since 2020 to address slowing economic growth. The shift in monetary policy, along with uncertainty surrounding the elections, has brought back the lure for dividend investing. While several dividend stocks could provide capital appreciation, zeroing in on stocks with a history of dividend growth leads to ...

Core Insights - Cabot Corporation's shares reached a 52-week high of $110.98, closing at $107.85, with a stock appreciation of 55.8% over the past year, contrasting with a 4.3% decline in the industry [1] - The Performance Chemicals division saw sales increase by 8.1% year over year to $332 million, with EBIT rising 72% to $55 million, driven by strong demand in automotive, infrastructure, and semiconductor markets [1][2] - The Reinforcement Materials segment also experienced growth due to increased volumes in Europe and Asia Pacific, along with improved pricing and product mix [2] Financial Outlook - Cabot raised its fiscal 2024 adjusted EPS guidance to $7.00-$7.10, reflecting a 30-cent increase at the midpoint, driven by anticipated strong results from both the Performance Chemicals and Reinforcement Materials segments [2] - The Zacks Consensus Estimate for fiscal 2024 earnings is $7.07, indicating a 31.4% year-over-year increase, with expected earnings growth of 10.6% in fiscal 2025 [3] Earnings Performance - The company has consistently surpassed the Zacks Consensus Estimate in the last four quarters, with an average earnings surprise of 8.6% [3] - In the past two months, the Zacks Consensus Estimate for Cabot's fiscal 2024 earnings has been revised upward by 4.3% [3] Market Position - Cabot currently holds a Zacks Rank 2 (Buy), indicating a favorable market position [4]

Have you been paying attention to shares of Cabot (CBT) ? Shares have been on the move with the stock up 8.8% over the past month. The stock hit a new 52-week high of $108.39 in the previous session. Cabot has gained 28.7% since the start of the year compared to the -3.7% move for the Zacks Basic Materials sector and the -2.3% return for the Zacks Chemical - Diversified industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our ear ...

Cabot Corporation's (CBT) shares have increased 18% in the past six months compared with the industry's growth of 0.6% and the S&P 500's appreciation of 7.8% during the same period. Image Source: Zacks Investment Research Let's look at the factors driving the stock's price movement. What's Driving Cabot? In the fiscal third quarter, Cabot's Performance Chemicals division posted robust growth, with sales climbing 8.1% year over year to $332 million. The segment's EBIT surged 72% to $55 million, driven by hig ...

Wall Street is off to a poor start in September on renewed concerns about the health of the economy and the stock market's historical performance. Amid such a backdrop, investors are increasingly exploring strategies that will help them to protect their portfolios from downside risk. And nothing seems better than the strategy of dividend investing. Picking stocks with a history of dividend growth leads to a healthy portfolio with a greater scope of capital appreciation as opposed to simple dividend-paying s ...

Core Insights - Cabot Corporation (CBT) has experienced a 20.4% increase in stock value over the past six months, driven by strong earnings performance and positive revisions to earnings guidance [1] - The stock is considered an attractive investment opportunity with strong growth prospects, reflected in its Zacks Rank 2 (Buy) [1] Earnings Performance - CBT has consistently outperformed the Zacks Consensus Estimate, achieving positive earnings surprises in the last four quarters with an average surprise of 8.6% [2] - The Zacks Consensus Estimate for CBT's fiscal 2024 earnings is projected at $7.07, indicating a 31.4% increase from the previous year, with a further 10.6% increase expected in fiscal 2025 [3] Earnings Estimates Revision - In the last two months, the Zacks Consensus Estimate for CBT's fiscal 2024 earnings has been raised by 4.3%, while the estimate for fiscal 2025 has seen a 3.9% upward revision [4] Stock Performance Comparison - Over the past year, Cabot's shares have surged 41.7%, contrasting with an 8.2% decline in the industry [5] Business Segment Performance - In the fiscal third quarter, Cabot's Performance Chemicals division reported an 8.1% year-over-year sales growth, reaching $332 million, with EBIT increasing by 72% to $55 million due to higher volumes and a favorable product mix [5] - The Reinforcement Materials segment also benefited from increased volumes in Europe and Asia Pacific, along with improved pricing and product mix in 2024 customer agreements [6] Future Outlook - The company has raised its fiscal 2024 adjusted EPS guidance to a range of $7.00-$7.10, reflecting an increase of 30 cents at the midpoint, based on expected strong results from the Performance Chemicals segment and continued strength in the Reinforcement Materials unit [7]

For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Cabot (CBT) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Cabot is one of 236 individual stocks in the Basic Materials sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individua ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely o ...

Cabot Corporation's (CBT) shares reached a fresh 52-week high of $105.30 on Aug 23 before closing at $104.24. In the past year, the stock has appreciated 48.3% against the industry's 6.1% decline in the same period. Image Source: Zacks Investment Research What's Driving Cabot? In the fiscal third quarter, Cabot's Performance Chemicals division posted an impressive 8.1% year-over-year sales growth, reaching $332 million. The segment's EBIT jumped by around 72% to $55 million. The substantial EBIT growth was ...